Headquartered in Columbus, Ohio, E Med Future manufactures and markets a revolutionary needle destruction device, NeedleZap®, developed specifically to help reduce accidental needlestick injuries in the workplace.
When a used hypodermic needle is inserted into the unit, the patented electrode system completely disintegrates the needle in approximately two seconds at 2200oF, leaving the syringe intact. NeedleZap® is portable, rechargeable and can accommodate a wide range of needle gauges.
With the March 14, 2003 approval order from the FDA, E Med can market NeedleZap® to an extensive audience base that includes (but not limited to) physicians, hospitals/clinics, home healthcare providers, long term care facilities, dental care professionals, veterinary facilities, law enforcement professionals, hospitality venues, the military and homeland security personnel. The company currently has worldwide distribution agreements with American Health & Safety Products, Inc., and their wholly owned subsidiary AHSP International L.L.C., who have representation in the United States, Europe, China, South America, Central America and Canada.
E Med Future is a publicly traded company. E Med completed a reverse merger with Las Vegas-based Micro-Economics, Inc. on April 17, 2003. Concurrent with the merger, the surviving company retained the E Med Future, Inc. name and changed its trading symbol to EMDF.OB. The company’s common stock began trading that same day on the NASDAQ Over-the-Counter Bulletin Board.
The company plans to continue its focus on bringing new products to the marketplace through its own internal research and development efforts, as well as through acquisitions and licensing of new products from a broad array of external sources. On June 17, 2003, E Med announced the signing of a strategic alliance agreement with UTEK Corporation (AMEX: UTK), an innovative technology transfer company. UTEK will identify and evaluate new university and federal laboratory technologies that compliment E Med’s business strategies.
Please see the "NEWS" section of the website for the most up-to-date information.
For more information, contact:
E Med Future, Inc. |
Phone: 1-330-674-1363
|
794 Morrison Road, Suite 911 |
|
Columbus, Ohio 43230 |
|
|
Stock Symbol: OTCBB: EMDF
|
|
